{"AllianceGenome": "5120", "HGNC": "5120", "MIM": "142964", "_id": "3219", "_version": 1, "accession": {"genomic": ["AC103702.3", "AH010085.2", "CH471109.2", "CP068261.2", "KT585248.1", "NC_000017.11", "NC_060941.1", "X16172.1"], "protein": ["AAG42144.1", "AAH15565.1", "BAG37864.1", "BAG51703.1", "BBI90107.1", "CAA34294.1", "EAW94721.1", "NP_076922.1", "P17482.2"], "rna": ["AK026084.1", "AK056123.1", "AK056414.1", "AK315480.1", "BC015565.1", "BF305592.1", "BX114117.1", "CA426693.1", "DA696753.1", "DA712230.1", "LC466645.1", "NM_024017.5"], "translation": [{"protein": "NP_076922.1", "rna": "NM_024017.5"}, {"protein": "BAG51703.1", "rna": "AK056414.1"}, {"protein": "BBI90107.1", "rna": "LC466645.1"}, {"protein": "BAG37864.1", "rna": "AK315480.1"}, {"protein": "AAH15565.1", "rna": "BC015565.1"}]}, "alias": ["HOX-2.5", "HOX2", "HOX2E"], "ensembl": {"gene": "ENSG00000170689", "protein": "ENSP00000309439", "transcript": "ENST00000311177", "translation": [{"protein": "ENSP00000309439", "rna": "ENST00000311177"}], "type_of_gene": "protein_coding"}, "entrezgene": "3219", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 4.66522847745, "exp_mis": 119.642751761, "exp_syn": 73.7456917549, "lof_z": 1.22232794207669, "mis_z": 1.59384093498207, "mu_lof": 3.87523621603e-07, "mu_mis": 1.19858449132e-05, "mu_syn": 7.52252099967e-06, "n_lof": 2.0, "n_mis": 84.0, "n_syn": 44.0, "p_li": 0.101637476227325, "p_null": 0.125103630295517, "p_rec": 0.773258893477158, "syn_z": 2.14736147373733}, "bp": 753, "cds_end": 46703631, "cds_start": 46700261, "n_exons": 2, "nonpsych": {"exp_lof": 4.18466681608, "exp_mis": 108.250423699, "exp_syn": 66.7091569046, "lof_z": 1.04883376704319, "mis_z": 1.56344293922172, "mu_lof": 3.87523621603e-07, "mu_mis": 1.19858449132e-05, "mu_syn": 7.52252099967e-06, "n_lof": 2.0, "n_mis": 76.0, "n_syn": 40.0, "p_li": 0.0941481044944471, "p_null": 0.157322447589584, "p_rec": 0.748529447915969, "syn_z": 2.05887958403517}, "nontcga": {"exp_lof": 4.28832441332, "exp_mis": 110.067653778, "exp_syn": 67.8423582395, "lof_z": 1.56643404495398, "mis_z": 1.61779018426817, "mu_lof": 3.87523621603e-07, "mu_mis": 1.19858449132e-05, "mu_syn": 7.52252099967e-06, "n_lof": 1.0, "n_mis": 76.0, "n_syn": 40.0, "p_li": 0.362826519695348, "p_null": 0.050633395353952, "p_rec": 0.5865400849507, "syn_z": 2.14031630663853}, "transcript": "ENST00000311177.5"}, "exons": [{"cdsend": 48626269, "cdsstart": 48622899, "chr": "17", "position": [[48621156, 48623135], [48625752, 48626358]], "strand": -1, "transcript": "NM_024017", "txend": 48626358, "txstart": 48621156}], "exons_hg19": [{"cdsend": 46703631, "cdsstart": 46700261, "chr": "17", "position": [[46698518, 46700497], [46703114, 46703720]], "strand": -1, "transcript": "NM_024017", "txend": 46703720, "txstart": 46698518}], "generif": [{"pubmed": 17148583, "text": "ERK5 probably mediates HOXB9 expression by repressing BMI1 in Hodgkin lymphoma cell lines"}, {"pubmed": 19341834, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19576624, "text": "Two WNT target genes, LEF1 and HOXB9, are identified as promoters of lung adenocarcinoma metastasis and mediators of chemotactic invasion and colony outgrowth."}, {"pubmed": 20080567, "text": "deregulated expression of HOXB9 contributes to breast cancer progression and lung metastasis by inducing several growth factors that alter tumor-specific cell fates and the tumor stromal microenvironment"}, {"pubmed": 21428455, "text": "HOXB9 is an E2-responsive gene and ERs coordinate with MLL1 and MLL3 in E2-mediated transcriptional regulation of HOXB9."}, {"pubmed": 21930940, "text": "The effect of HOXB9 on the response to ionizing radiation requires the baseline ATM activity before irradiation and epithelial-to-mesenchymal transition induced by TGF-beta."}, {"pubmed": 22225776, "text": "reduced expression of CD56 is associated with homeobox B9 in papillary thyroid carcinomas. Further, silencing of homeobox B9 is more common in older age and is linked to extrathyroidal extension and advanced pathologic stage of papillary thyroid carcinoma"}, {"pubmed": 22396001, "text": "HOXB9 overexpression promoting tumor cell proliferation and angiogenesis is associated with breast cancer."}, {"pubmed": 22863320, "text": "HOXB9 is overexpressed in breast cancer tissue."}, {"pubmed": 23332081, "text": "HOXB9 is down-regulation in gastric carcinoma and may be a novel prognostic marker for poorer clinical outcome for patients with gastric carcinoma."}, {"pubmed": 23350386, "text": "The expression of HOXB9, its relationship to clinical factors in breast cancer and efficacy as a prognostic factor were discussed."}, {"pubmed": 24462859, "text": "Data show that the HOXB9 overexpression group had significantly shorter overall survival time than the HOXB9 downexpression group."}, {"pubmed": 24582746, "text": "HOXB9 overexpression increased the tumorigenicity of glioma cells in vivo. Moreover, the activation of transforming growth factor-beta1 contributed to HOXB9-induced oncogenic activities."}, {"pubmed": 24600698, "text": "rs2303486 may be associated with severity of developmental dysplaasia of the hip in Chinese Han females."}, {"pubmed": 25025961, "text": "HOXB9 promoted colon adenocarcinoma differentiation."}, {"pubmed": 25081022, "text": "HOXB9 promotes epithelial-to-mesenchymal transition via TGF-beta1 pathway in hepatocellular carcinoma cells."}, {"pubmed": 25136922, "text": "Identification of the transcription factor binding site of the HOXB9 promoter region suggests that E2F1 is a direct regulator of HOXB9 expression in breast cancer."}, {"pubmed": 25324169, "text": "High expression of HoxB9 is a prognostic marker for lung adenocarcinoma patients."}, {"pubmed": 25724625, "text": "Low HOXB9 expression promotes pancreatic ductal adenocarcinoma progression."}, {"pubmed": 25860510, "text": "Knock-down of HOXB9 expression decreased migration, invasion and proliferation but did not alter adhesion."}, {"pubmed": 26536658, "text": "the results of the present study suggested that HOXB9 is a tumor suppressor in gastric carcinoma, and its activity was controlled by different regulatory mechanisms such as the hexapeptide motif as a \"brake\" in this case"}, {"pubmed": 26544896, "text": "Expression of GalNAc-T14 or HOXB9 was strongly correlated with reduced recurrence-free survival in lung adenocarcinomas."}, {"pubmed": 26926958, "text": "HOXB9 interfered the activities of NF-kappaB, nuclear factor of activated T-cells (NFAT) and AP-1 but not retinoic acid receptor-related orphan receptor, resulting in attenuation of the production of selective cytokines in activated T cells."}, {"pubmed": 26991799, "text": "These findings suggest that hoxb7 and hoxb9 proteins might play a role in salivary gland tumourigenesis, but in contrast to the reported for other human cancers, they were not significant prognostic determinants in the sample studied"}, {"pubmed": 27279480, "text": "We also found that FAT10 may act its oncogenic functions through regulating HOXB9. Collectively, the results suggested that FAT10 may be a novel therapeutic target for osteosarcoma patients"}, {"pubmed": 27613418, "text": "AcK27-HOXB9 suppresses the transcription of its target gene Jumonji domain-containing protein 6 (JMJD6) by direct occupying the promoter of JMJD6 gene."}, {"pubmed": 28298545, "text": "These findings integrate the complexity of numerous mechanisms of anti-VEGF resistance into the single transcription factor HOXB9. Silencing HOXB9 could be a promising approach to modulate this resistance. Our results candidate HOXB9 as predictive biomarker for selecting colorectal cancer patients for antiangiogenic therapy"}, {"pubmed": 28656236, "text": "Study demonstrated that HOXB9 may facilitate hypertrophic scar formation via activating the mitogenactivated protein kinase signaling pathway."}, {"pubmed": 28808656, "text": "this study revealed that HOXB9, HOXB13, and HOXD13 were upregulated and may play important roles in laryngeal squamous cell carcinoma (LSCC). Moreover, HOXB9 may serve as a novel marker of poor prognosis and a potential therapeutic target in LSCC patients."}, {"pubmed": 29408459, "text": "HOXB9 directly binds to the promoter of microRNA-765 and facilitates its transcription, which in turn targets FOXA2, resulting in a FOXA2 decrease and cancer stem cell increase. Elevated HOXB9 is found in human melanoma tissues, which is associated with microRNA-765 up-regulation and FOXA2 decreases."}, {"pubmed": 29654889, "text": "Results show the AcK27-HOXB9 level decreased in colon cancer patients and predicted better outcome. HOXB9 upregulated oncogenic EZH2 expression, whereas AcK27-HOXB9 suppressed it by translocating HOXB9 from nuclei into cytoplasm. AcK27-HOXB9 inhibits while non-acetylated HOXB9 promotes EZH2 expression and colon cancer progression. Thus, AcK27-HOXB9 underlies the tumor suppressive role of HOXB9."}, {"pubmed": 29724991, "text": "HOXB9 promotes endometrial cancer progression by targeting E2F3."}, {"pubmed": 31310747, "text": "High HOXB9 expression is associated with invasion and metastasis of hepatocellular carcinoma by chaperoning LRP6."}, {"pubmed": 31372881, "text": "Acetylated HOXB9 at lysine 27 is of differential diagnostic value in patients with pancreatic ductal adenocarcinoma."}, {"pubmed": 31504243, "text": "Homeobox B9 integrates bone morphogenic protein 4 with inflammation at atheroprone sites."}, {"pubmed": 31970886, "text": "Mutually exclusive antiproliferative effect of cell line-specific HOX inhibition in epithelial ovarian cancer cell lines: SKOV-3 vs RMUG-S."}, {"pubmed": 32098919, "text": "Silencing of HOXB9 suppresses cellular proliferation, angiogenesis, migration and invasion of prostate cancer cells."}, {"pubmed": 33214683, "text": "HOX genes promote cell proliferation and are potential therapeutic targets in adrenocortical tumours."}, {"pubmed": 33411683, "text": "HOXB9 enhances the ability of lung cancer cells to penetrate the blood-brain barrier."}, {"pubmed": 34036228, "text": "Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Responses."}, {"pubmed": 34247196, "text": "Insights into homeobox B9: a propeller for metastasis in dormant prostate cancer progenitor cells."}, {"pubmed": 34508900, "text": "WT1 regulates HOXB9 gene expression in a bidirectional way."}, {"pubmed": 34948228, "text": "A Systematic Review on HOX Genes as Potential Biomarkers in Colorectal Cancer: An Emerging Role of HOXB9."}, {"pubmed": 35182659, "text": "HOXB9 blocks cell cycle progression to inhibit pancreatic cancer cell proliferation through the DNMT1/RBL2/c-Myc axis."}, {"pubmed": 35216396, "text": "HOXB9 Overexpression Promotes Colorectal Cancer Progression and Is Associated with Worse Survival in Liver Resection Patients for Colorectal Liver Metastases."}, {"pubmed": 35634239, "text": "HOXB9 mediates resistance to chemotherapy and patient outcomes through the TGFbeta pathway in pancreatic cancer."}, {"pubmed": 36158877, "text": "Homeobox B9 Promotes the Progression of Hepatocellular Carcinoma via TGF-beta1/Smad and ERK1/2 Signaling Pathways."}, {"pubmed": 37031492, "text": "HOXB9 a miR-122-5p regulated gene, suppressed the anticancer effects of brusatol by upregulating SCD1 expression in melanoma."}, {"pubmed": 37205792, "text": "Activation of CTHRC1 by HOXB9 Promotes Angiogenesis through Fatty Acid Metabolism in Lung Adenocarcinoma."}, {"pubmed": 37258980, "text": "Homeobox B9 Promotes Colon Cancer Progression by Targeting SRSF3."}, {"pubmed": 38621423, "text": "HOXB9 promotes osteosarcoma cell survival and malignancy under glucose starvation via upregulating SPP1 expression."}, {"pubmed": 38632141, "text": "HOXB9 promotes laryngeal squamous cell carcinoma progression by upregulating MMP12."}], "genomic_pos": {"chr": "17", "end": 48626358, "ensemblgene": "ENSG00000170689", "start": 48621156, "strand": -1}, "genomic_pos_hg19": {"chr": "17", "end": 46703839, "start": 46698518, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0006351", "qualifier": "involved_in", "term": "DNA-templated transcription"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006357", "qualifier": "involved_in", "term": "regulation of transcription by RNA polymerase II"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0009952", "qualifier": "involved_in", "term": "anterior/posterior pattern specification"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0009954", "qualifier": "involved_in", "term": "proximal/distal pattern formation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030879", "qualifier": "involved_in", "term": "mammary gland development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0045944", "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0048704", "qualifier": "involved_in", "term": "embryonic skeletal system morphogenesis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0060326", "pubmed": 19576624, "qualifier": "involved_in", "term": "cell chemotaxis"}], "CC": [{"evidence": "ISA", "gocategory": "CC", "id": "GO:0000785", "qualifier": "part_of", "term": "chromatin"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0090575", "qualifier": "part_of", "term": "RNA polymerase II transcription regulator complex"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0000978", "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "ISA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IBA", "id": "GO:0003700", "qualifier": "enables", "term": "DNA-binding transcription factor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [10617598, 16189514, 19060904, 21516116, 25416956, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:1990837", "pubmed": 28473536, "qualifier": "enables", "term": "sequence-specific double-stranded DNA binding"}]}, "homologene": {"genes": [[7955, 30344], [8364, 394474], [9031, 771865], [9598, 749186], [9606, 3219], [9615, 608958], [9913, 783873], [10090, 15417], [10116, 287647]], "id": 7367}, "interpro": [{"desc": "Homeobox domain", "id": "IPR001356", "short_desc": "Homeobox_dom"}, {"desc": "Hox9, N-terminal activation domain", "id": "IPR006711", "short_desc": "Hox9_activation_N"}, {"desc": "Homeobox-like domain superfamily", "id": "IPR009057", "short_desc": "Homeobox-like_sf"}, {"desc": "Homeobox protein HXA9/HXB9/HXC9", "id": "IPR017112", "short_desc": "HXA9/HXB9/HXC9"}, {"desc": "Homeobox, conserved site", "id": "IPR017970", "short_desc": "Homeobox_CS"}, {"desc": "Homeobox domain, metazoa", "id": "IPR020479", "short_desc": "Homeobox_metazoa"}], "ipi": ["IPI00014539", "IPI00902521", "IPI01022289"], "map_location": "17q21.32", "name": "homeobox B9", "other_names": ["homeo box 2E", "homeo box B9", "homeobox protein Hox-2.5", "homeobox protein Hox-2E", "homeobox protein Hox-B9"], "pantherdb": {"HGNC": "5120", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "96190", "ortholog_type": "LDO", "panther_family": "PTHR45970", "taxid": 10090, "uniprot_kb": "P20615"}, {"RGD": "1306158", "ortholog_type": "LDO", "panther_family": "PTHR45970", "taxid": 10116, "uniprot_kb": "D3ZW24"}, {"Ensembl": "ENSGALG00000001276", "ortholog_type": "LDO", "panther_family": "PTHR45970", "taxid": 9031, "uniprot_kb": "E1BQM6"}, {"ZFIN": "ZDB-GENE-990415-109", "ortholog_type": "LDO", "panther_family": "PTHR45970", "taxid": 7955, "uniprot_kb": "Q9PWM2"}], "uniprot_kb": "P17482"}, "pathway": {"biocarta": {"id": "btg2pathway", "name": "btg family proteins and cell cycle regulation"}}, "pfam": ["PF00046", "PF04617"], "pharmgkb": "PA29396", "pharos": {"target_id": 17235, "tdl": "Tbio"}, "pir": "A37042", "prosite": "PS50071", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF167844", "relationship": "is"}, {"id": "GNF178750", "relationship": "is"}, {"id": "GNF189656", "relationship": "is"}, {"id": "GNF200562", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF161120", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF006660", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF095494", "relationship": "is"}, {"id": "GNF135151", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000017.11", "NC_060941.1"], "protein": "NP_076922.1", "rna": "NM_024017.5", "translation": {"protein": "NP_076922.1", "rna": "NM_024017.5"}}, "reporter": {"HG-U133_Plus_2": ["216417_x_at", "226461_at"], "HTA-2_0": "TC17001647.hg.1", "HuEx-1_0": "3761451", "HuGene-1_1": "8016476", "HuGene-2_1": "16846291"}, "summary": "This gene is a member of the Abd-B homeobox family and encodes a protein with a homeobox DNA-binding domain. It is included in a cluster of homeobox B genes located on chromosome 17. The encoded nuclear protein functions as a sequence-specific transcription factor that is involved in cell proliferation and differentiation. Increased expression of this gene is associated with some cases of leukemia, prostate cancer and lung cancer. [provided by RefSeq, Jul 2008].", "symbol": "HOXB9", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1415672"}, "unigene": "Hs.463350", "uniprot": {"Swiss-Prot": "P17482", "TrEMBL": "B3KPJ1"}, "wikipedia": {"url_stub": "HOXB9"}}